Gregor Paul

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe et al. · Clinical Microbiology and Infection · 2021 · 219 citations · Full text

Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19

Sixten Körper, Daniel Zickler, Thomas Wiesmann et al. · Journal of Clinical Investigation · 2021 · 88 citations · Full text

Clinical Management, Immunohematology, Control Group +14

Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial

Achim J. Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez‐Baño et al. · The Lancet Infectious Diseases · 2024 · 69 citations

Early Oral Switch, Healthcare-associated Infection, Patient Safety +6

Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia

Adrian Frick, Vineeta Khare, Gregor Paul et al. · Molecular Cancer Research · 2018 · 68 citations · Full text

IL10R2 Overexpression Promotes IL22/STAT3 Signaling in Colorectal Carcinogenesis

Vineeta Khare, Gregor Paul, Oliver Movadat et al. · Cancer Immunology Research · 2015 · 40 citations